Registry for adults with bronchiectasis and non-tuberculosis lung bacteria
Part of Infections, Lungs & breathing clinical trials.
This study is a registry that collects health information from adults who have bronchiectasis caused by non-tuberculosis mycobacteria (NTM). It helps researchers better understand this condition and improve future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years old or older
- You have bronchiectasis that is not related to cystic fibrosis (CF)
- You have non-tuberculosis mycobacteria (NTM) in your lungs
- You cannot be under 18 years old
- You cannot have CF-related bronchiectasis
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study will build a Canadian registry for people with bronchiectasis (not from cystic fibrosis) and NTM infections. The goal is to track health outcomes over time to improve care.
This is a research registry that collects information from adults diagnosed with nontuberculous mycobacterial (NTM) lung disease. It may help doctors better understand the disease and improve care over time.
This study looks at the community of tiny organisms in the lungs (the lung microbiome) in people with bronchiectasis caused by NTM (non-tuberculous mycobacteria). It compares people with positive NTM cultures to people without, to better understand what’s going on in the lungs and why symptoms may differ.
This study compares the health of people with NTM lung disease (not on antibiotics) to people with bronchiectasis (who have never had NTM infection). It aims to understand how these conditions affect daily life.
This study creates a registry of patients in Austria who have a lung infection caused by tuberculosis or similar bacteria. By joining, you help researchers learn more about these infections and how to better treat them.
This study looks at how bronchiectasis (ongoing lung damage with mucus and infections) may happen by using your medical records and genetic information. It may help researchers find better ways to understand different bronchiectasis types and guide future treatments.
Hear when a new Non-CF Bronchiectasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.